Brain Connectivity in Age-Related Macular Degeneration
Cognitive Changes and Brain Connectivity in Age-Related Macular Degeneration
2 other identifiers
observational
238
1 country
1
Brief Summary
This study is to determine how cognitive deficits (e.g.,verbal fluency deficit) in patients with Age-Related Macular Degeneration (AMD) relate to specific aspects of brain and function. The study team will assess whether the "brain signatures" associated with specific cognitive deficits differ in older adults with and without AMD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2013
CompletedFirst Posted
Study publicly available on registry
November 27, 2013
CompletedStudy Start
First participant enrolled
April 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedFebruary 7, 2019
December 1, 2018
4.2 years
November 22, 2013
February 6, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Cognitive Changes and Brain Connectivity in Age-Related Macular Degeneration
All Participants will receive neurocognitive testing, health and lifestyle surveys, audiometry and eye exams. Brain MRIs will be obtained on half the cohort, as this will provide sufficient power to accomplish the Aims that involve neuroimaging data. These MRIs will be obtained while participants are in the "resting state" meaning they are awake but not instructed to perform specific scanner. Two years after baseline exams, participants will return for repeat data collection. Participants who received an MRI at baseline will receive repeat resting-state, brain MRI at 2-year follow-up, unless they have developed contradictions to MRI scans in the interim.
Baseline, anticipated 2 years
Study Arms (2)
AMD controls
AMD cases
Eligibility Criteria
This study will include 300 participants: 150 subjects with AMD plus 150 age, gender, and education-matched adults without AMD. All participants will receive baseline and 2 year neurocognitive tests and a subset will provide structural and "resting stage"functional magnetic resonance images (MRIs) at each time point.
You may qualify if:
- AMD
- \- Vision loss attributable to AMD
- Controls
- Age match (± 5 yrs)
- Gender match
- Education match (± 4yrs)
- Normal macular exam
You may not qualify if:
- AMD
- Other significant eye pathology
- Mod/severe dementia
- Communication barrier that precludes testing
- Controls
- Other significant eye pathology
- Mod/severe dementia
- Communication barrier that precludes testing
- MRI subset
- Devices or material incompatible with 3.0 Tesla MRI
- Conditions that may interfere with interpretation of fMRI (e.g. history of stroke, brain tumor or previous brain surgery; psychoactive medications; seizure disorder)
- Claustrophobia
- Left-handed
- Body weight \> 300 lbs
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heather Whitson, MD
Duke Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2013
First Posted
November 27, 2013
Study Start
April 1, 2014
Primary Completion
June 1, 2018
Study Completion
June 1, 2018
Last Updated
February 7, 2019
Record last verified: 2018-12